Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity

beta-Amyloid (A beta), a major constituent of senile plaques in Alzheimer's disease (AD), is thought to contribute to the neurodegeneration. We examined the effects of nicotinic receptor agonists on AP cytotoxicity in cultured rat cortical neurons. The number of viable neurons decreased significantly when cultures were exposed to synthetic AP peptides (25-35). Concomitant administration of nicotine with AP markedly reduced the number of dead cells. This nicotine-induced neuroprotection was dependent on the concentration. When hexamethonium or mecamylamine, nicotinic antagonist, was added, neuroprotective effect of nicotine was blocked, which indicates that effect of nicotine was mediated by nicotinic receptors, In addition, a selective alpha 7-receptor antagonist, cw-bungarotoxin (alpha-BTX), blocked the neuroprotective effect of nicotine. Furthermore, incubation with 3-(2,4)-dimethoxybenzylidene anabaseine (DMXB), a selective alpha 7-receptor agonist, protected against AP-induced neuronal death. These results suggest that alpha 7-receptor activation plays an important role in neuroprotection against AP cytotoxicity. This study suggests that nicotinic receptor stimulation, especially alpha 7-receptor activation, may be able to protect neurons from degeneration induced by AP and may have effects that counter the progress of AD.